InnVentis Precision Medicine 2014
7 likes4,133 views
Precision medicine represents a shift from symptom-based and intuition-based medicine of the past to a data-driven approach using an individual's molecular and genomic data to guide prevention, diagnosis, and treatment decisions. By applying rules, algorithms and reference databases to integrate multiple types of data such as molecular fingerprints, imaging, and non-molecular content, precision medicine enables actionable clinical decision support and precise, efficient care tailored to each individual.
1 of 1
Downloaded 127 times
Recommended
From Big Data to Precision Medicine 
From Big Data to Precision Medicine Year of the X
油
From Big Data to Precision Medicine @Dr. Thomas Wilckens (Innventis)
21st April 2016 at Year of the Monkey in Munich Paradigmshift in precision medicine
Paradigmshift in precision medicineAlex Beer
油
TreatmentMAP
TreatmentMAP supports physicians in optimizing their treatment decisions, even for cancer patients in advanced stages of cancer, or when all of the standard treatment options for a patient have been exhausted.Precision medicine the future of_healthcare
Precision medicine the future of_healthcareThomas Wilckens
油
InnVentis provides precision medicine through analyzing personal molecular profiles derived from multi-omics data and the internet of things to recommend diets and supplements personalized to each individual's daily schedule.Transcriptional Science
Transcriptional ScienceThomas Wilckens
油
Transctriptional Science aims to re-evaluate existing data in the context of the translational sciences paradim in order to secure reliability and validity of data used for hypothesis generation, project design and decision making at a highest possible level of confidencePattern diagnostics 2015
Pattern diagnostics 2015Thomas Wilckens
油
The document discusses the emerging field of precision medicine and how it represents a shift from symptom-based to evidence-based to personalized medicine. Precision medicine utilizes large datasets including multi-omics data, imaging, and other clinical data combined with machine learning algorithms and reference databases to generate personalized molecular profiles and enable targeted prevention and treatment. Key to realizing precision medicine's potential is establishing standards, processes, and reference databases to facilitate large-scale data analysis and ensure results can be reproduced.The reality of moving towards precision medicine
The reality of moving towards precision medicineElia Stupka
油
How do we move towards precision medicine? How can we deliver on the big data in health promise? Who will be the enablers and players? Pharma, Big Tech, or newcomers?Precision Medicine: Research Presentation
Precision Medicine: Research PresentationShelagh McLellan
油
The document discusses opportunities for improving healthcare through precision medicine and integrating genomic and quantified self data. It identifies several pain points in the current healthcare system such as inefficient appointments and a lack of preventative care. Interviews with patients and providers revealed that neither group fully understands genetic data and they desire more participation. The aim is to present a vision for how genomic data could influence health services through opportunities like providing actionable steps based on genetic counseling, combining family history with genomic data, and enabling preventative health measures from a young age.UCSF Informatics Day 2014 - Keith R. Yamamoto, "Precision Medicine"
UCSF Informatics Day 2014 - Keith R. Yamamoto, "Precision Medicine"CTSI at UCSF
油
Keith R. Yamamoto, PhD Opening Remarks Precision Medicine
Vice Chancellor for Research
Executive Vice Dean of the School of Medicine
Professor of Cellular and Molecular Pharmacology
UCSFAutomated image analysis: rescue for diffusion-MRI of threat to radiologists?
Automated image analysis: rescue for diffusion-MRI of threat to radiologists?Erik R. Ranschaert, MD, PhD
油
Is the increasing availability of automated image analysis a possibility to strengthen the application of diffusion-MRI as a biometric parameter, and to enhance the future of image biobanks? Or is this evolution threatening the position of radiologists as medical doctors. Is a redefinition of radiologist as computer technicians inevitable? Thomas Willkens-El impacto de las ciencias 坦micas en la medicina, la nutrici坦...
Thomas Willkens-El impacto de las ciencias 坦micas en la medicina, la nutrici坦...Fundaci坦n Ram坦n Areces
油
El 29 de marzo de 2016 celebramos un Simposio Internacional sobre el 'Impacto de las ciencias 坦micas en la medicina, nutrici坦n y biotecnolog鱈a'. Organizado por la Fundaci坦n Ram坦n Areces en colaboraci坦n con la Real Academia Nacional de Medicina y BioEuroLatina, abord坦 c坦mo un mejor conocimiento del genoma humano est叩 permitiendo notables avances hacia una medicina de precisi坦n. Data Science in Drug Discovery
Data Science in Drug DiscoveryWrangleConf
油
Presenter: Marina Sirota, UCSF
Recent advances in genome typing and sequencing technologies have enabled quick generation of a vast amount of molecular data at very low cost. The mining and computational analysis of this type of data can help shape new diagnostic and therapeutic strategies in biomedicine. In this talk, I will discuss how such technological advances in combination with data science and integrative analysis can be applied to drug discovery in the context of drug target identification, computational drug repurposing, and population stratification approaches.Personalized Medicine: Balancing the Promise and Peril of ... Personalized ...
Personalized Medicine: Balancing the Promise and Peril of ... Personalized ...MedicineAndHealth
油
This document discusses the promise and challenges of personalized medicine through pharmacogenomics. It explores opportunities like more effective drug development through tailoring therapies based on genetic differences. However, it also examines ethical issues such as deciding research priorities, demonstrating clinical utility with smaller trials, integrating testing into care, preventing discrimination and maintaining privacy and confidentiality. The document notes economic challenges around business decisions and costs, as well as social impacts on identity, health inequalities and creating feelings of fatalism or helplessness in some groups.Integrating Genomic Medicine into Patient Care with Trish Brown, MS, CGC
Integrating Genomic Medicine into Patient Care with Trish Brown, MS, CGCAsia Pacific Medical Technology Association (APACMed)
油
There are only around 500 geneticists and 2,400 genetic counselors in the U.S. to help integrate genomic medicine into patient care. DNA Direct aims to address this shortage and other barriers through technology solutions that provide education, decision support, and expert guidance to patients, providers, payors, and medical centers. Their programs have shown success in improving patient compliance with genetic screening and understanding of test results.EuroBioForum2014_speaker_Manolio
EuroBioForum2014_speaker_ManolioEuroBioForum
油
This document summarizes discussions from the 6th Genomic Medicine Colloquium hosted by the National Human Genome Research Institute. The colloquium brought together 50 international genomic medicine leaders from 25 countries to discuss opportunities for collaboration. Key areas of discussion included establishing standards for genomic data storage, implementing global pharmacogenomic screening programs, developing genomic medicine policy, and creating an international genomic medicine collaborative.EuroBioForum2014_sepaker_Palotie
EuroBioForum2014_sepaker_PalotieEuroBioForum
油
The document discusses the formation and goals of the Global Alliance for Genomics and Health. It was started in 2013 to facilitate international sharing of genomic and clinical data. Its goals are to establish common frameworks for data sharing, catalyze specific data sharing projects, and demonstrate the value of aggregating data from many sources. It currently has over 200 partner organizations from 30 countries. Working groups are advancing priorities around regulatory issues, data standards, security, and clinical implementation. The alliance aims to create a growing, sustainable network that continuously improves understanding of human health through large-scale data sharing and analysis.EuroBioForum2014_speaker_Balling
EuroBioForum2014_speaker_BallingEuroBioForum
油
The document discusses the work of the Luxembourg Centre for Systems Biomedicine (LCSB), an interdisciplinary research center that studies neurodegenerative diseases. The LCSB takes a systems approach and brings together experts from various fields including biology, computer science, engineering, and clinical science. Successful interdisciplinary work requires teamwork, proximity between researchers, increasing communication, and sharing credit. The document also discusses community-driven disease mapping projects and efforts to apply concepts from ecology to medicine, such as identifying early warning signals of disease.Big Datas Contribution to Precision Healthcare
Big Datas Contribution to Precision Healthcareprecisionmedicine1
油
Just as a corporation can improve its products and services by analyzing data and using relevant data points to steer future action, the healthcare industry can leverage big data in future decisions to the improvement of personalized medicine. But healthcare can use big data on more fronts than most industries, especially considering transition of healthcare into precision medicine. Visit: https://www.rockwestsolutions.com/sensors/medical-devices/Healthcare Conference 2013 : Genes, Clouds and Cancer - dr. Andrew Litt
Healthcare Conference 2013 : Genes, Clouds and Cancer - dr. Andrew LittD3 Consutling
油
Dell Healthcare provides IT services to healthcare organizations worldwide. They serve over 50% of US hospitals, the top 10 pharmaceutical companies, and 100 insurance organizations. Dell Healthcare manages billions of medical images in the cloud, billions of security events daily, and provides genomic sequencing services. They are sponsoring the first FDA-approved clinical trial using whole genome sequencing to provide personalized cancer treatment to children with neuroblastoma. The trial aims to reduce analysis time from weeks to hours using Dell's high performance computing capabilities and improve collaboration using their genomics cloud. The goal is to expand personalized medicine from treating a few children to hundreds and thousands.ENAR 2020
ENAR 2020Warren Kibbe
油
RWD, EHRs, PROs. Using data to inform the patient trajectory and experience. Given at the Virtual 2020 ENAR meeting. Modern Genomics in conjunction with Patients IP on the value chain
Modern Genomics in conjunction with Patients IP on the value chainJohn Peter Mary Wubbe
油
Perhaps it is now time to move past the classical dichotomy of privacy or data utility and to seize the possibilities of emerging health technologies, processes, and projects. Far from being harmful, Patient-controlled health records in collaboration with emerging technologies that work within a defined, over sighted and legislated regulatory framework will facilitate innumerable benefits.
There are a number of forthcoming statistical solutions that would permit assembly of data sets at a patient level with limited risk to privacy and also delineate the cumbersome contentions of data ownership and accessCould this change how radiology residents record their clinical output?
Could this change how radiology residents record their clinical output?Apparao Mukkamala
油
Radiology residents around the world typically record experiential learning (EL) in a clinical logbook, but according to a new study published in the Journal of Digital Imaging, modern PACS and RIS technology could very well be used to build the EL portfolios of the future. https://www.radiologybusiness.com/topics/imaging-informatics/pacs-ris-radiology-residents-clinical-outputPaul Coplan, VP, Johnson & Johnson_mHealth Israel
Paul Coplan, VP, Johnson & Johnson_mHealth IsraelLevi Shapiro
油
Pesentation, October 19th, 2021: Whats Next in RWE for Medical Devices: The Art of the Possible. Presented by Paul Coplan, ScD, MBA, FISPE, Vice President, Med Device Epidemiology and RWD Sciences, Johnson & Johnson; Adjunct Professor, Department of Biostatistics, Epidemiology and Informatics, University of Pennsylvania, Perelman School of Medicine; Fellow of the International Society of Pharmacoepidemiology
- Why RWE is Important for Medical Devices: Challenges with Clinical Trials of Medical Devices (Blinding, Surgeon skill/technique, Hospital process, Product modifications, Long term Follow up, Enrolment challenges)
- Types of Real-World Data Sources (Complaints like MAUDE, Eudramed and Company Databases, Hospital Databases, Electronic Health Records, Claims, Registries, Patient surveys, Surgeon surveys, PROs, Patient Preferences, wearables, sensors, social media, Surgical videos, device generated data, radiographic images)
- FDA CDRH Report on RWE Examples for Regulatory Decisions
- J&J Med Device Epidemiology & Real-World Data Sciences
- US National Evaluation System for Health Technology (NEST)
- RWE for Safety Assessments: Cobalt in Implants and at Work and Risk of Cancer
- Summary of Cobalt Exposure and All-Site Cancer Risk, by Study Type
- Comparative Effectiveness Studies Using RWE
- Summary
a. Use of RWE is important to benefit patients globally and enhance the safety and innovation of medical devices
b. Regulators are interested in using RWE for regulatory decisions but data quality and evidence needs to be regulatory grade
c. NEST has been a useful forum to advance the use of RWE for regulatory decisions in the US
d. RWE can be used for safety assessments, regulatory decisions, comparative effectiveness research, and R&D of products
Symbiotic innovation 082015
Symbiotic innovation 082015Thomas Wilckens
油
This document discusses the challenges of precision medicine and drug discovery, including vast amounts of biological data, high costs of R&D, and lack of standards. It proposes a new model called Symbiotic Innovation that establishes vertically integrated organizations headed by expert task forces to source internal and external competencies. This model aims to improve ROI through collaborative projects, proprietary databases, and potentially spinning off high-risk projects to new companies.iHT2 Health IT Summit San Francisco 2013 - Christopher Longhurst, MD, CMIO, L...
iHT2 Health IT Summit San Francisco 2013 - Christopher Longhurst, MD, CMIO, L...Health IT Conference iHT2
油
Christopher A. Longhurst, MD, MS
Chief Medical Information Officer
Lucile Packard Childrens Hospital
Clinical Associate Professor of Pediatrics
Stanford School of Medicine
Case Study "Using Big Data to Shift from Evidence-based Practice to Practice-based Evidence"
Packard Children's Hospital at Stanford has been on a journey towards a comprehensive electronic medical record (EMR) since 2004. These efforts resulted in national attention in 2010 with the publication of the first-ever correlation between implementation of computerized physician order entry (CPOE) and a decrease in hospital-wide mortality. This landmark was followed in 2011 with a paper in the NEJM describing the first documented use of aggregate EMR data to make a real-time patient care decision. In this talk, Dr. Chris Longhurst will share the "story behind the story" of these accomplishments and highlight opportunities for using applied clinical informatics to improve the value of healthcare we deliver to our patients.Personalized Medicine with IBM-Watson: Future of Cancer care
Personalized Medicine with IBM-Watson: Future of Cancer carejetweedy
油
Watson for Genomics uses IBM's Watson cognitive computing system to help personalize cancer care. It analyzes genomic sequencing data and clinical records to provide treatment suggestions and clinical trial matches for patients in minutes, compared to weeks for traditional approaches. Researchers are finalizing the algorithm and testing it in clinical trials. Watson draws from a large corpus of medical literature and patient data to understand questions, generate hypotheses, and provide evidence to support its answers. It could help reduce health professionals' workload and improve access to care, though challenges remain in developing the algorithm and acquiring sufficient data sets.Clinical analyticsinnovating to support clinical research 
Clinical analyticsinnovating to support clinical research Kent State University
油
Clinical research informatics involves using informatics tools to support clinical research activities like managing clinical trials data and conducting secondary research using clinical data. It can help make clinical trials more efficient by facilitating study design, subject recruitment from electronic medical records and social media, data collection and management, and data analysis. National initiatives aim to develop informatics tools and networks to help researchers access data and accelerate clinical research.Digital Pathology, FDA Approval and Precision Medicine
Digital Pathology, FDA Approval and Precision MedicineJoel Saltz
油
Digital pathology platforms combined with machine learning can improve the consistency and quality of clinical decision making by precisely scoring known criteria from pathology images and predicting treatment outcomes and cancer types. Researchers are developing tools to extract features from pathology images, link these features to molecular data and clinical outcomes, and use these integrated datasets to gain new insights into cancer and select the best interventions. The SEER Virtual Tissue Repository aims to enable population-level cancer research by creating a linked collection of de-identified clinical data and whole slide images from pathology samples that can be analyzed using computational methods.Pattern diagnostics 2015
Pattern diagnostics 2015Thomas Wilckens
油
The document discusses the emerging field of precision medicine and how it represents a shift from symptom-based to evidence-based to personalized medicine. Precision medicine utilizes large datasets including multi-omics data, imaging, and other clinical data combined with machine learning algorithms and pattern recognition to develop personalized molecular profiles and more precise diagnoses and treatments. Key challenges include the need for higher quality and standardized data as well as streamlined processes to validate findings and translate biomarker discovery into clinical applications.EY Drug R&D: Big DATA for big returns
EY Drug R&D: Big DATA for big returnsThomas Wilckens
油
This document discusses how big data can help reduce costs and increase productivity in drug R&D. It outlines challenges such as increased clinical trials, patients, and data requirements that have led to higher R&D costs. Big data is presented as a solution by bringing more insights from data rather than resources. The document provides case studies and a 6-step approach for companies to leverage big data in R&D, including establishing an analytics strategy, identifying relevant data sources, and optimizing their analytics organization.Gscheidl
GscheidlThomas Wilckens
油
This short document appears to be a joke legal disclaimer for a fictional Bavarian word or phrase. It notes that the content is a joke and copyrighted, while also stating that reproduction is allowed for educational purposes only.More Related Content
What's hot (19)
Automated image analysis: rescue for diffusion-MRI of threat to radiologists?
Automated image analysis: rescue for diffusion-MRI of threat to radiologists?Erik R. Ranschaert, MD, PhD
油
Is the increasing availability of automated image analysis a possibility to strengthen the application of diffusion-MRI as a biometric parameter, and to enhance the future of image biobanks? Or is this evolution threatening the position of radiologists as medical doctors. Is a redefinition of radiologist as computer technicians inevitable? Thomas Willkens-El impacto de las ciencias 坦micas en la medicina, la nutrici坦...
Thomas Willkens-El impacto de las ciencias 坦micas en la medicina, la nutrici坦...Fundaci坦n Ram坦n Areces
油
El 29 de marzo de 2016 celebramos un Simposio Internacional sobre el 'Impacto de las ciencias 坦micas en la medicina, nutrici坦n y biotecnolog鱈a'. Organizado por la Fundaci坦n Ram坦n Areces en colaboraci坦n con la Real Academia Nacional de Medicina y BioEuroLatina, abord坦 c坦mo un mejor conocimiento del genoma humano est叩 permitiendo notables avances hacia una medicina de precisi坦n. Data Science in Drug Discovery
Data Science in Drug DiscoveryWrangleConf
油
Presenter: Marina Sirota, UCSF
Recent advances in genome typing and sequencing technologies have enabled quick generation of a vast amount of molecular data at very low cost. The mining and computational analysis of this type of data can help shape new diagnostic and therapeutic strategies in biomedicine. In this talk, I will discuss how such technological advances in combination with data science and integrative analysis can be applied to drug discovery in the context of drug target identification, computational drug repurposing, and population stratification approaches.Personalized Medicine: Balancing the Promise and Peril of ... Personalized ...
Personalized Medicine: Balancing the Promise and Peril of ... Personalized ...MedicineAndHealth
油
This document discusses the promise and challenges of personalized medicine through pharmacogenomics. It explores opportunities like more effective drug development through tailoring therapies based on genetic differences. However, it also examines ethical issues such as deciding research priorities, demonstrating clinical utility with smaller trials, integrating testing into care, preventing discrimination and maintaining privacy and confidentiality. The document notes economic challenges around business decisions and costs, as well as social impacts on identity, health inequalities and creating feelings of fatalism or helplessness in some groups.Integrating Genomic Medicine into Patient Care with Trish Brown, MS, CGC
Integrating Genomic Medicine into Patient Care with Trish Brown, MS, CGCAsia Pacific Medical Technology Association (APACMed)
油
There are only around 500 geneticists and 2,400 genetic counselors in the U.S. to help integrate genomic medicine into patient care. DNA Direct aims to address this shortage and other barriers through technology solutions that provide education, decision support, and expert guidance to patients, providers, payors, and medical centers. Their programs have shown success in improving patient compliance with genetic screening and understanding of test results.EuroBioForum2014_speaker_Manolio
EuroBioForum2014_speaker_ManolioEuroBioForum
油
This document summarizes discussions from the 6th Genomic Medicine Colloquium hosted by the National Human Genome Research Institute. The colloquium brought together 50 international genomic medicine leaders from 25 countries to discuss opportunities for collaboration. Key areas of discussion included establishing standards for genomic data storage, implementing global pharmacogenomic screening programs, developing genomic medicine policy, and creating an international genomic medicine collaborative.EuroBioForum2014_sepaker_Palotie
EuroBioForum2014_sepaker_PalotieEuroBioForum
油
The document discusses the formation and goals of the Global Alliance for Genomics and Health. It was started in 2013 to facilitate international sharing of genomic and clinical data. Its goals are to establish common frameworks for data sharing, catalyze specific data sharing projects, and demonstrate the value of aggregating data from many sources. It currently has over 200 partner organizations from 30 countries. Working groups are advancing priorities around regulatory issues, data standards, security, and clinical implementation. The alliance aims to create a growing, sustainable network that continuously improves understanding of human health through large-scale data sharing and analysis.EuroBioForum2014_speaker_Balling
EuroBioForum2014_speaker_BallingEuroBioForum
油
The document discusses the work of the Luxembourg Centre for Systems Biomedicine (LCSB), an interdisciplinary research center that studies neurodegenerative diseases. The LCSB takes a systems approach and brings together experts from various fields including biology, computer science, engineering, and clinical science. Successful interdisciplinary work requires teamwork, proximity between researchers, increasing communication, and sharing credit. The document also discusses community-driven disease mapping projects and efforts to apply concepts from ecology to medicine, such as identifying early warning signals of disease.Big Datas Contribution to Precision Healthcare
Big Datas Contribution to Precision Healthcareprecisionmedicine1
油
Just as a corporation can improve its products and services by analyzing data and using relevant data points to steer future action, the healthcare industry can leverage big data in future decisions to the improvement of personalized medicine. But healthcare can use big data on more fronts than most industries, especially considering transition of healthcare into precision medicine. Visit: https://www.rockwestsolutions.com/sensors/medical-devices/Healthcare Conference 2013 : Genes, Clouds and Cancer - dr. Andrew Litt
Healthcare Conference 2013 : Genes, Clouds and Cancer - dr. Andrew LittD3 Consutling
油
Dell Healthcare provides IT services to healthcare organizations worldwide. They serve over 50% of US hospitals, the top 10 pharmaceutical companies, and 100 insurance organizations. Dell Healthcare manages billions of medical images in the cloud, billions of security events daily, and provides genomic sequencing services. They are sponsoring the first FDA-approved clinical trial using whole genome sequencing to provide personalized cancer treatment to children with neuroblastoma. The trial aims to reduce analysis time from weeks to hours using Dell's high performance computing capabilities and improve collaboration using their genomics cloud. The goal is to expand personalized medicine from treating a few children to hundreds and thousands.ENAR 2020
ENAR 2020Warren Kibbe
油
RWD, EHRs, PROs. Using data to inform the patient trajectory and experience. Given at the Virtual 2020 ENAR meeting. Modern Genomics in conjunction with Patients IP on the value chain
Modern Genomics in conjunction with Patients IP on the value chainJohn Peter Mary Wubbe
油
Perhaps it is now time to move past the classical dichotomy of privacy or data utility and to seize the possibilities of emerging health technologies, processes, and projects. Far from being harmful, Patient-controlled health records in collaboration with emerging technologies that work within a defined, over sighted and legislated regulatory framework will facilitate innumerable benefits.
There are a number of forthcoming statistical solutions that would permit assembly of data sets at a patient level with limited risk to privacy and also delineate the cumbersome contentions of data ownership and accessCould this change how radiology residents record their clinical output?
Could this change how radiology residents record their clinical output?Apparao Mukkamala
油
Radiology residents around the world typically record experiential learning (EL) in a clinical logbook, but according to a new study published in the Journal of Digital Imaging, modern PACS and RIS technology could very well be used to build the EL portfolios of the future. https://www.radiologybusiness.com/topics/imaging-informatics/pacs-ris-radiology-residents-clinical-outputPaul Coplan, VP, Johnson & Johnson_mHealth Israel
Paul Coplan, VP, Johnson & Johnson_mHealth IsraelLevi Shapiro
油
Pesentation, October 19th, 2021: Whats Next in RWE for Medical Devices: The Art of the Possible. Presented by Paul Coplan, ScD, MBA, FISPE, Vice President, Med Device Epidemiology and RWD Sciences, Johnson & Johnson; Adjunct Professor, Department of Biostatistics, Epidemiology and Informatics, University of Pennsylvania, Perelman School of Medicine; Fellow of the International Society of Pharmacoepidemiology
- Why RWE is Important for Medical Devices: Challenges with Clinical Trials of Medical Devices (Blinding, Surgeon skill/technique, Hospital process, Product modifications, Long term Follow up, Enrolment challenges)
- Types of Real-World Data Sources (Complaints like MAUDE, Eudramed and Company Databases, Hospital Databases, Electronic Health Records, Claims, Registries, Patient surveys, Surgeon surveys, PROs, Patient Preferences, wearables, sensors, social media, Surgical videos, device generated data, radiographic images)
- FDA CDRH Report on RWE Examples for Regulatory Decisions
- J&J Med Device Epidemiology & Real-World Data Sciences
- US National Evaluation System for Health Technology (NEST)
- RWE for Safety Assessments: Cobalt in Implants and at Work and Risk of Cancer
- Summary of Cobalt Exposure and All-Site Cancer Risk, by Study Type
- Comparative Effectiveness Studies Using RWE
- Summary
a. Use of RWE is important to benefit patients globally and enhance the safety and innovation of medical devices
b. Regulators are interested in using RWE for regulatory decisions but data quality and evidence needs to be regulatory grade
c. NEST has been a useful forum to advance the use of RWE for regulatory decisions in the US
d. RWE can be used for safety assessments, regulatory decisions, comparative effectiveness research, and R&D of products
Symbiotic innovation 082015
Symbiotic innovation 082015Thomas Wilckens
油
This document discusses the challenges of precision medicine and drug discovery, including vast amounts of biological data, high costs of R&D, and lack of standards. It proposes a new model called Symbiotic Innovation that establishes vertically integrated organizations headed by expert task forces to source internal and external competencies. This model aims to improve ROI through collaborative projects, proprietary databases, and potentially spinning off high-risk projects to new companies.iHT2 Health IT Summit San Francisco 2013 - Christopher Longhurst, MD, CMIO, L...
iHT2 Health IT Summit San Francisco 2013 - Christopher Longhurst, MD, CMIO, L...Health IT Conference iHT2
油
Christopher A. Longhurst, MD, MS
Chief Medical Information Officer
Lucile Packard Childrens Hospital
Clinical Associate Professor of Pediatrics
Stanford School of Medicine
Case Study "Using Big Data to Shift from Evidence-based Practice to Practice-based Evidence"
Packard Children's Hospital at Stanford has been on a journey towards a comprehensive electronic medical record (EMR) since 2004. These efforts resulted in national attention in 2010 with the publication of the first-ever correlation between implementation of computerized physician order entry (CPOE) and a decrease in hospital-wide mortality. This landmark was followed in 2011 with a paper in the NEJM describing the first documented use of aggregate EMR data to make a real-time patient care decision. In this talk, Dr. Chris Longhurst will share the "story behind the story" of these accomplishments and highlight opportunities for using applied clinical informatics to improve the value of healthcare we deliver to our patients.Personalized Medicine with IBM-Watson: Future of Cancer care
Personalized Medicine with IBM-Watson: Future of Cancer carejetweedy
油
Watson for Genomics uses IBM's Watson cognitive computing system to help personalize cancer care. It analyzes genomic sequencing data and clinical records to provide treatment suggestions and clinical trial matches for patients in minutes, compared to weeks for traditional approaches. Researchers are finalizing the algorithm and testing it in clinical trials. Watson draws from a large corpus of medical literature and patient data to understand questions, generate hypotheses, and provide evidence to support its answers. It could help reduce health professionals' workload and improve access to care, though challenges remain in developing the algorithm and acquiring sufficient data sets.Clinical analyticsinnovating to support clinical research
Clinical analyticsinnovating to support clinical research Kent State University
油
Clinical research informatics involves using informatics tools to support clinical research activities like managing clinical trials data and conducting secondary research using clinical data. It can help make clinical trials more efficient by facilitating study design, subject recruitment from electronic medical records and social media, data collection and management, and data analysis. National initiatives aim to develop informatics tools and networks to help researchers access data and accelerate clinical research.Digital Pathology, FDA Approval and Precision Medicine
Digital Pathology, FDA Approval and Precision MedicineJoel Saltz
油
Digital pathology platforms combined with machine learning can improve the consistency and quality of clinical decision making by precisely scoring known criteria from pathology images and predicting treatment outcomes and cancer types. Researchers are developing tools to extract features from pathology images, link these features to molecular data and clinical outcomes, and use these integrated datasets to gain new insights into cancer and select the best interventions. The SEER Virtual Tissue Repository aims to enable population-level cancer research by creating a linked collection of de-identified clinical data and whole slide images from pathology samples that can be analyzed using computational methods.Automated image analysis: rescue for diffusion-MRI of threat to radiologists?
Automated image analysis: rescue for diffusion-MRI of threat to radiologists?Erik R. Ranschaert, MD, PhD
油
Thomas Willkens-El impacto de las ciencias 坦micas en la medicina, la nutrici坦...
Thomas Willkens-El impacto de las ciencias 坦micas en la medicina, la nutrici坦...Fundaci坦n Ram坦n Areces
油
Integrating Genomic Medicine into Patient Care with Trish Brown, MS, CGC
Integrating Genomic Medicine into Patient Care with Trish Brown, MS, CGCAsia Pacific Medical Technology Association (APACMed)
油
iHT2 Health IT Summit San Francisco 2013 - Christopher Longhurst, MD, CMIO, L...
iHT2 Health IT Summit San Francisco 2013 - Christopher Longhurst, MD, CMIO, L...Health IT Conference iHT2
油
More from Thomas Wilckens (6)
Pattern diagnostics 2015
Pattern diagnostics 2015Thomas Wilckens
油
The document discusses the emerging field of precision medicine and how it represents a shift from symptom-based to evidence-based to personalized medicine. Precision medicine utilizes large datasets including multi-omics data, imaging, and other clinical data combined with machine learning algorithms and pattern recognition to develop personalized molecular profiles and more precise diagnoses and treatments. Key challenges include the need for higher quality and standardized data as well as streamlined processes to validate findings and translate biomarker discovery into clinical applications.EY Drug R&D: Big DATA for big returns
EY Drug R&D: Big DATA for big returnsThomas Wilckens
油
This document discusses how big data can help reduce costs and increase productivity in drug R&D. It outlines challenges such as increased clinical trials, patients, and data requirements that have led to higher R&D costs. Big data is presented as a solution by bringing more insights from data rather than resources. The document provides case studies and a 6-step approach for companies to leverage big data in R&D, including establishing an analytics strategy, identifying relevant data sources, and optimizing their analytics organization.Gscheidl
GscheidlThomas Wilckens
油
This short document appears to be a joke legal disclaimer for a fictional Bavarian word or phrase. It notes that the content is a joke and copyrighted, while also stating that reproduction is allowed for educational purposes only.Precision Medicine in Hawaiian: Kina'ole
Precision Medicine in Hawaiian: Kina'oleThomas Wilckens
油
Precision medicine aims to provide individualized healthcare by taking into account individual variability in genes, environment, and lifestyle for each person. It seeks to do "the right thing, in the right way, at the right time" for each individual patient. An ancient Hawaiian word, Kinaole, encapsulates this goal of precision medicine to achieve flawless, personalized care tailored to each person.Reverse Innovation 2014
Reverse Innovation 2014Thomas Wilckens
油
Reverse Innovation offers the unique opportunity to develop innovativ solutions for exponentially growing problems/markets in an often less regulated (emerging) markets leapfrogging incremental product and market developments in established markets.Disruption By Mobile 042012
Disruption By Mobile 042012Thomas Wilckens
油
mobile ICT-technologies will lead to the disruption of health care including R&D as we currently know it; since regulated markets pose significant hurdle on innovation, reverse innovation appears to be the logic consequence to improved the efficacy of health care as well as the way therapeutic concepts are being developed. Personalized medicine will become reality in a completely new dimension which are deriving from remote diganostics converging with innovative drugs to theranostics.Recently uploaded (20)
MORPHOLOGICAL FEATURES OF PNEUMONIA.....
MORPHOLOGICAL FEATURES OF PNEUMONIA.....maheenmazhar021
油
This presentation provides a detailed exploration of the morphological and microscopic features of pneumonia, covering its histopathology, classification, and clinical significance. Designed for medical students, pathologists, and healthcare professionals, this lecture differentiates bacterial vs. viral pneumonia, explains lobar, bronchopneumonia, and interstitial pneumonia, and discusses diagnostic imaging patterns.
Key Topics Covered:
Normal lung histology vs. pneumonia-affected lung
Morphological changes in lobar, bronchopneumonia, and interstitial pneumonia
Microscopic features: Fibroblastic plugs, alveolar septal thickening, inflammatory cell infiltration
Stages of lobar pneumonia: Congestion, Red hepatization, Gray hepatization, Resolution
Common causative pathogens (Streptococcus pneumoniae, Klebsiella pneumoniae, Mycoplasma, etc.)
Clinical case study with diagnostic approach and differentials
Who Should Watch?
This is an essential resource for medical students, pathology trainees, and respiratory health professionals looking to enhance their understanding of pneumonias morphological aspects.BIOMECHANICS OF THE MOVEMENT OF THE SHOULDER COMPLEX.pptx
BIOMECHANICS OF THE MOVEMENT OF THE SHOULDER COMPLEX.pptxdrnidhimnd
油
The shoulder complex acts as in coordinated fashion to provide the smoothest and greatest range of motion possible of the upper limb.
Combined motion of GH and ST joint of shoulder complex helps in:
Distribution of motion between other two joints.
Maintenance of glenoid fossa in optimal position.
Maintenance of good length tension
Although some amount of glenohumeral motion may occur while the other shoulder articulations remain stabilized, movement of the humerus more commonly involves some movement at all three shoulder joints.
Description of Beta thalassemia its cause and management.
Description of Beta thalassemia its cause and management.KIMS
油
All about Beta Thalassemia etiology , pathology , manifestation and treatment & prevention..
physiology 1 T3T4 & Jaundice & capillary circulation 愕悗悋.pptx
physiology 1 T3T4 & Jaundice & capillary circulation 愕悗悋.pptxamralmohammady27
油
惺惆 悋惡 惠惡 悖 惠悋惡惠 悋
power point show
惺 悴惆悋 惘悋悴惺悸 愕惘惺悸 悸 悋悋惠忰悋
悋 惆惘 惺 忰悋悴悸 惺悋
愆惘悋 惆惠惘悸 悋 惺 惠悴惺悸 悖愕悧悸 悋惡Asthma: Causes, Types, Symptoms & Management A Comprehensive Overview
Asthma: Causes, Types, Symptoms & Management A Comprehensive OverviewDr Aman Suresh Tharayil
油
This presentation provides a detailed yet concise overview of Asthma, a chronic inflammatory disease of the airways. It covers the definition, etiology (causes), different types, signs & symptoms, and common triggers of asthma. The content highlights both allergic (extrinsic) and non-allergic (intrinsic) asthma, along with specific forms like exercise-induced, occupational, drug-induced, and nocturnal asthma.
Whether you are a healthcare professional, student, or someone looking to understand asthma better, this presentation offers valuable insights into the condition and its management.Op-eds and commentaries 101: U-M IHPI Elevating Impact series
Op-eds and commentaries 101: U-M IHPI Elevating Impact seriesKara Gavin
油
A slide set about writing opinion and commentary pieces, created for the University of Michigan Institute for Healthcare Policy and Innovation in Jan. 2025
Diabetic Ketoacidosis (DKA) & Its Management Protocol
Diabetic Ketoacidosis (DKA) & Its Management ProtocolDr Anik Roy Chowdhury
油
Dr. Anik Roy Chowdhury
MBBS, BCS(Health), DA, MD (Resident)
Department of Anesthesiology, ICU & Pain Medicine
Shaheed Suhrawardy Medical College Hospital (ShSMCH)Sudurpaschim logsewa aayog Medical Officer 8th Level Curriculum
Sudurpaschim logsewa aayog Medical Officer 8th Level CurriculumDr Ovels
油
Sudurpaschim province psc ( lok sewa aayog) medical officer 8th level syllabusMultimodal Approaches to Clitoral Augmentation for FGM (PRP _ filler)"
Multimodal Approaches to Clitoral Augmentation for FGM (PRP _ filler)"Rehab Aboshama
油
Multimodal Approaches to Clitoral Augmentation for FGM (PRP _ filler)"
HER2-Targeting Therapy in HER2+ MBC With and Without CNS Metastases: Selectio...
HER2-Targeting Therapy in HER2+ MBC With and Without CNS Metastases: Selectio...PVI, PeerView Institute for Medical Education
油
Chair and Presenters Sara A. Hurvitz, MD, FACP, Carey K. Anders, MD, FASCO, and Vyshak Venur, MD, discuss metastatic HER2-positive breast cancer in this CME/NCPD/CPE/AAPA/IPCE activity titled Fine-Tuning the Selection and Sequencing of HER2-Targeting Therapies in HER2-Positive MBC With and Without CNS Metastases: Expert Guidance on How to Individualize Therapy Based on Latest Evidence, Disease Features, Treatment Characteristics, and Patient Needs and Preferences. For the full presentation, downloadable Practice Aids, and complete CME/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at https://bit.ly/4f8sUs7. CME/NCPD/CPE/AAPA/IPCE credit will be available until March 2, 2026.MALE REPRODUCTIVE PHYSIOLOGY up load.pptx
MALE REPRODUCTIVE PHYSIOLOGY up load.pptxYIHENEW CHALLIE LIYEW
油
Male animal reproductive physiology including sexual maturity ,reproductive hormone ,sperm production DIAGNOSIS OF PREGNANCY PPT IN ALL TRIMESTER
DIAGNOSIS OF PREGNANCY PPT IN ALL TRIMESTERdaminipatel37
油
Diagnosis of all three trimester of pregnancy 
Macafem Reviews 2024 - Macafem for Menopause Symptoms
Macafem Reviews 2024 - Macafem for Menopause SymptomsMacafem Supplement
油
At Macafem, we provide 100% natural support for women navigating menopause. For over 20 years, we've helped women manage symptoms, and in 2024, we're proud to share their heartfelt experiences.
Optimization in Pharmaceutical Formulations: Concepts, Methods & Applications
Optimization in Pharmaceutical Formulations: Concepts, Methods & ApplicationsKHUSHAL CHAVAN
油
This presentation provides a comprehensive overview of optimization in pharmaceutical formulations. It explains the concept of optimization, different types of optimization problems (constrained and unconstrained), and the mathematical principles behind formulation development. Key topics include:
Methods for optimization (Sequential Simplex Method, Classical Mathematical Methods)
Statistical analysis in optimization (Mean, Standard Deviation, Regression, Hypothesis Testing)
Factorial Design & Quality by Design (QbD) for process improvement
Applications of optimization in drug formulation
This resource is beneficial for pharmaceutical scientists, R&D professionals, regulatory experts, and students looking to understand pharmaceutical process optimization and quality by design approaches.Flag Screening in Physiotherapy Examination.pptx
Flag Screening in Physiotherapy Examination.pptxBALAJI SOMA
油
Flag screening is a crucial part of physiotherapy assessment that helps in identifying medical, psychological, occupational, and social barriers to recovery. Recognizing these flags ensures that physiotherapists make informed decisions, provide holistic care, and refer patients appropriately when necessary. By integrating flag screening into practice, physiotherapists can optimize patient outcomes and prevent chronicity of conditions.Acute & Chronic Inflammation, Chemical mediators in Inflammation and Wound he...
Acute & Chronic Inflammation, Chemical mediators in Inflammation and Wound he...Ganapathi Vankudoth
油
A complete information of Inflammation, it includes types of Inflammation, purpose of Inflammation, pathogenesis of acute inflammation, chemical mediators in inflammation, types of chronic inflammation, wound healing and Inflammation in skin repair, phases of wound healing, factors influencing wound healing and types of wound healing.HER2-Targeting Therapy in HER2+ MBC With and Without CNS Metastases: Selectio...
HER2-Targeting Therapy in HER2+ MBC With and Without CNS Metastases: Selectio...PVI, PeerView Institute for Medical Education
油
Acute & Chronic Inflammation, Chemical mediators in Inflammation and Wound he...
Acute & Chronic Inflammation, Chemical mediators in Inflammation and Wound he...Ganapathi Vankudoth
油
InnVentis Precision Medicine 2014
- 1. Precision Medicine - Paradigm Shift Symptom-based Pattern-based Algorithm-based Yesterday Intuition Medicine Today Evidence-based Medicine Tomorrow Precision Medicine DATAACTIONS Application of rules, algorithms and reference databases enables ACTIONABLE clinical decision support & PRECISE/EFFICIENT care Reference Databases (Rules & Algorithms) Personal Molecular Fingerprints (PMF, multi-omics) Molecular Imaging Non-molecular content (waveforms) Precision Medicine (prevention, diagnosis, treatment) Mobile Information Communication Technologies Big Data Analytics Precision Medicine 息 Dr. Thomas Wilckens, InnVentis